Matches in Wikidata for { <http://www.wikidata.org/entity/Q87887345> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q87887345 description "artículu científicu espublizáu en febreru de 2018" @default.
- Q87887345 description "scientific article published on 26 February 2018" @default.
- Q87887345 description "wetenschappelijk artikel" @default.
- Q87887345 description "наукова стаття, опублікована 26 лютого 2018" @default.
- Q87887345 name "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 name "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 type Item @default.
- Q87887345 label "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 label "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 prefLabel "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 prefLabel "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 P1433 Q87887345-CCDC3A13-4772-456B-B2C9-562A8B88B577 @default.
- Q87887345 P1476 Q87887345-E74F2DFC-C31D-4456-9E59-13894C1FEDD5 @default.
- Q87887345 P2093 Q87887345-01E54F1A-719E-40DC-BB9D-57C46E8A6A0C @default.
- Q87887345 P2093 Q87887345-26CA96B7-6CED-489F-8FF9-E255DD116A8B @default.
- Q87887345 P2093 Q87887345-476C71E9-4E49-4E49-8BB2-E328363B9C97 @default.
- Q87887345 P2093 Q87887345-8399DB57-BAA1-4FEC-8C55-128C0BCBA651 @default.
- Q87887345 P2093 Q87887345-ABAE540C-7FC7-42FE-B310-DE5723D741B4 @default.
- Q87887345 P2093 Q87887345-B05C7530-89E9-49E4-8B35-E3F5E6BFE231 @default.
- Q87887345 P2093 Q87887345-D2E7D800-50E0-4680-A5E8-18DB2C6C76EB @default.
- Q87887345 P2093 Q87887345-FC6E237C-561B-4245-8420-0809E2FA7373 @default.
- Q87887345 P2093 Q87887345-FD77FD2B-E4D1-47AE-BFAD-DB2E7BC9C549 @default.
- Q87887345 P304 Q87887345-3F8EED18-0D50-401F-B3D2-78808B78FBFB @default.
- Q87887345 P31 Q87887345-A11F1DE0-CCE3-4A57-BC80-E71E3E2CE553 @default.
- Q87887345 P356 Q87887345-E45583A0-9BB4-4D8B-8BA6-A37C8606D47E @default.
- Q87887345 P433 Q87887345-47BF7930-9770-4264-8D01-BA1F01AD2890 @default.
- Q87887345 P478 Q87887345-E58E534F-D358-4CD5-9826-0441B12EFB16 @default.
- Q87887345 P50 Q87887345-3639EF6D-A96B-46A0-916A-6BD8B9988DA4 @default.
- Q87887345 P577 Q87887345-2B4F6669-A0BF-4074-94DD-716D16D07C8C @default.
- Q87887345 P698 Q87887345-940BD750-57F1-4FDC-8071-F4857B7F0A46 @default.
- Q87887345 P921 Q87887345-215BF85F-F901-44DD-9857-E391D907258F @default.
- Q87887345 P921 Q87887345-31F35272-E2D9-4498-9372-C3465DD4FBC5 @default.
- Q87887345 P356 ANNRHEUMDIS-2017-212496 @default.
- Q87887345 P698 29483080 @default.
- Q87887345 P1433 Q4767876 @default.
- Q87887345 P1476 "Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study" @default.
- Q87887345 P2093 "Benjamin Hsu" @default.
- Q87887345 P2093 "Michael H Schiff" @default.
- Q87887345 P2093 "Peter C Taylor" @default.
- Q87887345 P2093 "Qingmin Wang" @default.
- Q87887345 P2093 "Ravi Rao" @default.
- Q87887345 P2093 "Regina Kurrasch" @default.
- Q87887345 P2093 "Shruti Daga" @default.
- Q87887345 P2093 "Yanli Zhuang" @default.
- Q87887345 P2093 "Yusang Jiang" @default.
- Q87887345 P304 "658-666" @default.
- Q87887345 P31 Q13442814 @default.
- Q87887345 P356 "10.1136/ANNRHEUMDIS-2017-212496" @default.
- Q87887345 P433 "5" @default.
- Q87887345 P478 "77" @default.
- Q87887345 P50 Q89865007 @default.
- Q87887345 P577 "2018-02-26T00:00:00Z" @default.
- Q87887345 P698 "29483080" @default.
- Q87887345 P921 Q187255 @default.
- Q87887345 P921 Q348260 @default.